Key Target Audience Organizations and Entities Who Can Benefit by Subscribing This Report: Hospitals and Healthcare Providers Erythropoietin Drug Manufacturers Government and Regulatory Bodies (e.g., CDSCO, NITI Aayog) Investment and Venture Capitalist Firms Banks and Financial Institutions Private Equity Firms